Works matching AU Zimmermann, Annamaria

Results: 9

Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non--Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2014, v. 15, n. 6, p. 418, doi. 10.1016/j.cllc.2014.06.007

By:

Pujol, Jean-Louis;
Paz-Ares, Luis;
de Marinis, Filippo;
Dediu, Mircea;
Thomas, Michael;
Bidoli, Paolo;
Corral, Jesus;
San Antonio, Belen;
Chouaki, Nadia;
John, William;
Zimmermann, Annamaria;
Visseren-Grul, Carla;
Gridelli, Cesare

Publication type:

Article

A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.

Published in:

Cancer (0008543X), 2011, v. 117, n. 20, p. 4732, doi. 10.1002/cncr.26068

By:

Kirkwood, John M.;
Gonzalez, Rene;
Reintgen, Douglas;
Clingan, Philip R.;
McWilliams, Robert R.;
de Alwis, Dinesh P.;
Zimmermann, Annamaria;
Brown, Michael P.;
Ilaria, Robert L.;
Millward, Michael J.

Publication type:

Article

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY.

Published in:

Cancer Science, 2020, v. 111, n. 12, p. 4510, doi. 10.1111/cas.14655

By:

Nishio, Makoto;
Seto, Takashi;
Reck, Martin;
Garon, Edward B.;
Chiu, Chao‐Hua;
Yoh, Kiyotaka;
Imamura, Fumio;
Park, Keunchil;
Shih, Jin‐Yuan;
Visseren‐Grul, Carla;
Frimodt‐Moller, Bente;
Zimmermann, Annamaria;
Homma, Gosuke;
Enatsu, Sotaro;
Nakagawa, Kazuhiko

Publication type:

Article

RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure-response relationship.

Published in:

2022

By:

Nakagawa, Kazuhiko;
Garon, Edward B.;
Gao, Ling;
Callies, Sophie;
Zimmermann, Annamaria;
Walgren, Richard;
Visseren-Grul, Carla;
Reck, Martin

Publication type:

journal article

Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer.

Published in:

2018

By:

Smit, Egbert F.;
Garon, Edward B.;
Reck, Martin;
Cappuzzo, Federico;
Bidoli, Paolo;
Cohen, Roger B.;
Gao, Ling;
O’Brien, Lisa M.;
Lee, Pablo;
Zimmermann, Annamaria;
Ferry, David R.;
Melemed, Allen S.;
Pérol, Maurice;
O'Brien, Lisa M

Publication type:

journal article

Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer.

Published in:

Current Medical Research & Opinion, 2020, v. 36, n. 10, p. 1667, doi. 10.1080/03007995.2020.1808781

By:

Yoh, Kiyotaka;
Atagi, Shinji;
Reck, Martin;
Garon, Edward B.;
Ponce Aix, Santiago;
Moro-Sibilot, Denis;
Winfree, Katherine B.;
Frimodt-Moller, Bente;
Zimmermann, Annamaria;
Visseren-Grul, Carla;
Nakagawa, Kazuhiko

Publication type:

Article

Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

Published in:

2018

By:

Middleton, Gary;
Gridelli, Cesare;
De Marinis, Filippo;
Pujol, Jean-Louis;
Reck, Martin;
Ramlau, Rodryg;
Parente, Barbara;
Pieters, Thierry;
Visseren-Grul, Carla M.;
San Antonio, Bélen;
John, William J.;
Zimmermann, Annamaria Hayden;
Chouaki, Nadia;
Paz-Ares, Luis

Publication type:

journal article

Exposure‐response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 7, p. 3182, doi. 10.1111/bcp.15233

By:

de Wit, Ronald;
Powles, Thomas;
Castellano, Daniel;
Necchi, Andrea;
Lee, Jae‐Lyun;
van der Heijden, Michiel S.;
Matsubara, Nobuaki;
Bamias, Aristotelis;
Fléchon, Aude;
Sternberg, Cora N.;
Drakaki, Alexandra;
Yu, Evan Y.;
Zimmermann, Annamaria H.;
Long, Amanda;
Walgren, Richard A.;
Gao, Ling;
Bell‐McGuinn, Katherine M.;
Petrylak, Daniel P.

Publication type:

Article

East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

Published in:

Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1177, doi. 10.4143/crt.2015.401

By:

Keunchil Park;
Joo-Hang Kim;
Eun Kyung Cho;
Jin-Hyoung Kang;
Jin-Yuan Shih;
Zimmermann, Annamaria Hayden;
Pablo Lee;
Alexandris, Ekaterine;
Puri, Tarun;
Orlando, Mauro

Publication type:

Article